Insider Holders & Insider Ownership - SUPERNUS PHARMACEUTICALS INC. (SUPN)

List of insiders holdings for SUPERNUS PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
NEA PARTNERS 11 LP
10% Owner
2015-11-12 15:46:572,345,864
7,641,250
9,987,114Form 4
BARRIS PETER J
10% Owner
2015-11-12 15:46:030
6,687,021
6,687,021Form 4
SANDELL SCOTT D
10% Owner
2015-11-12 15:48:440
6,674,600
6,674,600Form 4
BASKETT FOREST
10% Owner
2015-11-12 15:47:320
6,663,538
6,663,538Form 4
KOLLURI KRISHNA KITTU
10% Owner
2015-11-12 15:48:020
6,198,544
6,198,544Form 4
Khattar Jack A.
President, CEO
2024-09-03 17:00:12926,172
1,022,450
1,948,622Form 4
Abingworth Management LTD
10% Owner
2015-04-21 13:08:331,459,965
0
1,459,965Form 13D
ORBIMED ADVISORS LLC
ISALY SAMUEL D
ORBIMED CAPITAL GP II LLC
10% Owner
2013-08-20 16:23:471,122,300
0
1,122,300Form 13D
SHEFFERY MICHAEL B
Director
2012-05-07 11:44:320
297,815
297,815Form 4
BARRETT M JAMES
Director
2016-03-24 09:01:0997,355
115,355
212,710Form 4
NEWHALL CHARLES W III
Director
2024-02-27 17:04:34120,975
0
120,975Form 4
Vaughn Victor
Sr. VP of Sales & Marketing
2018-04-20 16:53:07118,994
0
118,994Form 4
Pinschewer David
Chief Scientific Officer
2019-04-24 17:33:04116,416
0
116,416Form 4
Bryan Jones W.
VP of Business Development
2015-03-31 16:57:2498,743
0
98,743Form 4
Martin Tami Tillotson
Sr. V.P., Regulatory Affairs
2024-02-27 17:00:2290,683
0
90,683Form 4
SIEBERT JOHN M
Director
2024-02-27 17:02:5287,943
0
87,943Form 4
PATRICK GREGORY S
Sr. VP Chief Financial Officer
2020-11-10 16:19:0654,463
0
54,463Form 4
Matushansky Igor
Chief Medical Officer
2019-04-24 17:33:0452,064
0
52,064Form 4
GEMAYEL GEORGES
Director
2024-09-17 16:10:4838,315
0
38,315Form 4
Hudson Frederick M.
Director
2024-02-27 17:03:2637,117
0
37,117Form 4
BIGHAM MICHAEL
Director
2013-03-26 16:33:148,722
25,000
33,722Form 4
Nuerge William A.
Director
2017-06-15 16:42:5129,786
0
29,786Form 4
Barlow Carrolee
Director
2024-02-27 17:04:2417,201
0
17,201Form 4
Kelly James Patrick
Executive Vice-President & CFO
2021-02-23 18:55:1615,000
0
15,000Form 4
DEC TIMOTHY C
Senior Vice-President & CFO
2024-02-27 17:01:3414,690
0
14,690Form 4
Sensenig Bethany
Director
2024-02-26 17:01:4713,621
0
13,621Form 4
Bhatt Padmanabh P.
Sr. VP of IP, CSO
2024-08-20 17:00:159,679
0
9,679Form 4
Rubin Jonathan
SVP, Chief Medical Officer
2024-02-27 17:00:518,391
0
8,391Form 4
Mottola Frank
SVP, Quality, GMP, Ops, IT
2024-02-29 17:01:467,779
0
7,779Form 4
Lengauer Christoph
Director
2019-04-24 17:32:476,924
0
6,924Form 4
Schwabe Stefan K.F.
Executive Vice President & CMO
2020-12-22 17:49:472,772
0
2,772Form 4
NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BARRIS PETER J
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
KRAMLICH C RICHARD
PERRY MARK W
SANDELL SCOTT D
10% Owner
2015-12-10 14:05:330
0
0Form 13D
NEW ENTERPRISE ASSOCIATES 11 LP
10% Owner
2015-12-10 14:05:330
0
0Form 13D